本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

51.76
-0.8100-1.54%
盘后52.000.2400+0.46%18:35 EDT
成交量:299.54万
成交额:1.55亿
市值:98.95亿
市盈率:-12.64
高:52.85
开:52.49
低:50.91
收:52.57
52周最高:52.85
52周最低:21.72
股本:1.91亿
流通股本:1.51亿
量比:1.38
换手率:1.98%
股息:- -
股息率:- -
每股收益(TTM):-4.0935
每股收益(LYR):-2.8793
净资产收益率:-1789.67%
总资产收益率:-41.96%
市净率:-5.53
市盈率(LYR):-17.98

数据加载中...

2025/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

重要事件披露

Form 8-K - Current report
2025/07/02

重要事件披露

Form 8-K - Current report
2025/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/23

重要事件披露

Form 8-K - Current report
2025/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities